ICLR iconplc.com: Net earnings per share for the last four quarters

Public company logo of ICON Plc (ICLR)

The impeccable scientific authority of ICON Public (ICLR) guarantees the trust of global pharma behemoths. Comparing the current EPS YoY shift over the last 12 months on GURU.Markets, we see that the indicator value is 43.70. This trend reflects deep digital integration into clients' R&D processes and high business resilience driven by broad geographical reach and a diverse customer base.

ICLR (ICON plc) Earnings per share for the last twelve months history from 02/11/2024 to 11/15/2026

ICON - analytical breakdowns and key metrics (ICLR)

- price and consensus price forecast:
Initial company analysis:ICLR, ICON Public Limited Company
Original product of iconplc.com

Reduced R&D spending by pharmaceutical behemoths and patient recruitment challenges directly impact the operational efficiency of ICON Public (ICLR). These factors drive the dynamics of the rolling annual net income per share growth, stripping financial results of market noise. This indicator measures the real profitability of the business, confirming sustainable growth or signaling an impending drawdown. By analyzing this rolling year-over-year EPS growth chart, an investor assesses the fundamental viability of the company.